Literature DB >> 20865569

[Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.].

Yasemin Deveci1, Figen Deveci, Nevin Ilhan, Ilgın Karaca, Teyfik Turgut, Mehmet Hamdi Muz.   

Abstract

It is determined that endocrine factors can play role on cachexia in chronic obstructive pulmonary disease (COPD). High levels of ghrelin is reported in cachectic COPD cases but its' relation couldn't shown statistically. In our study, it is aimed to detect serum ghrelin levels in COPD, its' relation with proinflammatory cytokines and whether serum ghrelin is associated with cachexia. Sixty stable COPD patients and 15 healthy volunteers were included in the study. COPD patients were divided into two groups, cachectic and normal weight, according to their body mass index. Spirometric assessments were performed and serum tumor necrosis factor-alpha (TNF-a), interleukin-6 (IL-6) and ghrelin levels were measured in all cases. When COPD patients were compared with control group; serum ghrelin levels were statistically lower, TNF-a and IL-6 levels were statistically higher in COPD group. For cachectic COPD patients; serum ghrelin levels were statistically lower and IL-6 levels were statistically higher, compared with normal weight COPD patients. Although, serum TNF-a levels were higher for cachectic COPD patients; these levels were not significant. Positive correlation between serum ghrelin levels and body mass index was detected in patients with COPD. As a result; it is thought that increased proinflammatory cytokines and decreased serum active ghrelin levels may contribute to the development of weight loss.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865569

Source DB:  PubMed          Journal:  Tuberk Toraks        ISSN: 0494-1373


  4 in total

1.  Evaluation of ghrelin level and appetite regulation in patients with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Ye Wang; Yongchun Shen; Qiunan Zuo; Li Zhao; Chun Wan; Panwen Tian; Lei Chen; Fuqiang Wen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-14

Review 2.  Therapeutic Potential of Targeting the Ghrelin Pathway.

Authors:  Gustav Colldén; Matthias H Tschöp; Timo D Müller
Journal:  Int J Mol Sci       Date:  2017-04-11       Impact factor: 5.923

3.  Risk of dementia or cognitive impairment in COPD patients: A meta-analysis of cohort studies.

Authors:  Jun Wang; Xuanlin Li; Siyuan Lei; Dong Zhang; Shujuan Zhang; Hailong Zhang; Jiansheng Li
Journal:  Front Aging Neurosci       Date:  2022-09-09       Impact factor: 5.702

Review 4.  Elevated circulating ghrelin in patients with COPD: A meta-analysis.

Authors:  Xue Zhang; Ting Yang; Junli Wang; Mei Feng; Yan Hou; Yongchun Shen; Lei Chen
Journal:  Chron Respir Dis       Date:  2018-02-27       Impact factor: 2.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.